06:26 EDT Athira Pharma (ATHA) files $300M mixed securities shelf
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATHA:
- Athira Pharma downgraded to Neutral from Outperform at Mizuho
- Athira Pharma to focus on ATH-1105 advancement, reduces workforce by 70%
- Goldman Sachs moves Athira Pharma to Not Rated
- Athira Pharma downgraded to Neutral from Buy at Rodman & Renshaw
- Athira Pharma downgraded to Market Perform from Outperform at JMP Securities